Karolinska Universitetssjukhuset, Huddinge
About Karolinska Universitetssjukhuset, Huddinge
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
6
Pfizer
6
Celgene
5
Takeda
4
Vertex Pharmaceuticals Incorporated
4
Amgen
3
Biogen
3
Stichting Hemato-Oncologie voor Volwassenen Nederland
3
CHDI Foundation, Inc.
2
Hoffmann-La Roche
2
Karolinska Institutet
2
Clinical Trials at Karolinska Universitetssjukhuset, Huddinge
During the past decade, Karolinska Universitetssjukhuset, Huddinge conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 19 clinical trials were completed, i.e. on
average, 41.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
1998-07-01
2011-08-01
Completed
360
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
2004-07-01
2014-08-01
Completed
637
The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT
2004-10-01
2005-05-01
Completed
162
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
2006-02-01
2008-05-01
Completed
231
Efficacy of Acetylcysteine in Patients Undergoing Surgery for Otosclerosis
2007-09-01
2013-04-01
Completed
152
Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.
2008-07-01
Completed
27
A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).
2008-09-01
2010-11-01
Completed
118
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Karolinska Universitetssjukhuset, Huddinge" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Pfizer" with 6 trials
sponsored, "Celgene" with 5 trials sponsored, "Takeda" with 4 trials sponsored and "Vertex Pharmaceuticals Incorporated"
with 4 trials sponsored. Other sponsors include 42 different institutions and
companies that sponsored additional 41 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Karolinska Universitetssjukhuset, Huddinge"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Karolinska Institutet" with 2 trials as a collaborator, "Linkoeping University" with 2 trials as a collaborator, "Uppsala University" with 2 trials as a collaborator and "AFA Insurance" with 1 trials as a collaborator. Other collaborators include 32 different institutions and companies that were
collaborators in the rest 42 trials.
Clinical Trials Conditions at Karolinska Universitetssjukhuset, Huddinge
According to Clinical.Site data, the most researched conditions in "Karolinska Universitetssjukhuset, Huddinge" are
"Multiple Myeloma" (8 trials), "Alzheimer's Disease" (6 trials), "Cystic Fibrosis" (4 trials), "Acute Myeloid Leukemia" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Karolinska Universitetssjukhuset, Huddinge" in a lesser frequency.
Clinical Trials Intervention Types at Karolinska Universitetssjukhuset, Huddinge
Most popular intervention types in "Karolinska Universitetssjukhuset, Huddinge" are "Drug" (53 trials), "Other" (10 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "IVA" (4 trials), "ELX/TEZ/IVA" (3 trials), "Placebo (matched to ELX/TEZ/IVA)" (3 trials) and "Placebo (matched to IVA)" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Karolinska Universitetssjukhuset, Huddinge
The vast majority of trials in "Karolinska Universitetssjukhuset, Huddinge" are
68 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Karolinska Universitetssjukhuset, Huddinge
Currently, there are NaN active trials in "Karolinska Universitetssjukhuset, Huddinge".
undefined are not yet recruiting,
13 are recruiting,
18 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in Karolinska Universitetssjukhuset, Huddinge,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Karolinska Universitetssjukhuset, Huddinge, 1 "Phase 1"
clinical trials were conducted, 17 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 10 trials that are defined as “Not Applicable".